Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Aug 28;359(9):895-905.
doi: 10.1056/NEJMoa0801187.

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy

Dwight J Rouse  1 , Deborah G Hirtz, Elizabeth Thom, Michael W Varner, Catherine Y Spong, Brian M Mercer, Jay D Iams, Ronald J Wapner, Yoram Sorokin, James M Alexander, Margaret Harper, John M Thorp Jr, Susan M Ramin, Fergal D Malone, Marshall Carpenter, Menachem Miodovnik, Atef Moawad, Mary J O'Sullivan, Alan M Peaceman, Gary D V Hankins, Oded Langer, Steve N Caritis, James M Roberts; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network
Collaborators, Affiliations
Randomized Controlled Trial

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy

Dwight J Rouse et al. N Engl J Med. .

Abstract

Background: Research suggests that fetal exposure to magnesium sulfate before preterm birth might reduce the risk of cerebral palsy.

Methods: In this multicenter, placebo-controlled, double-blind trial, we randomly assigned women at imminent risk for delivery between 24 and 31 weeks of gestation to receive magnesium sulfate, administered intravenously as a 6-g bolus followed by a constant infusion of 2 g per hour, or matching placebo. The primary outcome was the composite of stillbirth or infant death by 1 year of corrected age or moderate or severe cerebral palsy at or beyond 2 years of corrected age.

Results: A total of 2241 women underwent randomization. The baseline characteristics were similar in the two groups. Follow-up was achieved for 95.6% of the children. The rate of the primary outcome was not significantly different in the magnesium sulfate group and the placebo group (11.3% and 11.7%, respectively; relative risk, 0.97; 95% confidence interval [CI], 0.77 to 1.23). However, in a prespecified secondary analysis, moderate or severe cerebral palsy occurred significantly less frequently in the magnesium sulfate group (1.9% vs. 3.5%; relative risk, 0.55; 95% CI, 0.32 to 0.95). The risk of death did not differ significantly between the groups (9.5% vs. 8.5%; relative risk, 1.12; 95% CI, 0.85 to 1.47). No woman had a life-threatening event.

Conclusions: Fetal exposure to magnesium sulfate before anticipated early preterm delivery did not reduce the combined risk of moderate or severe cerebral palsy or death, although the rate of cerebral palsy was reduced among survivors. (ClinicalTrials.gov number, NCT00014989.)

PubMed Disclaimer

Figures

Figure 1
Figure 1
Enrollment, Randomization, and Follow-up of the Study Participants.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Executive Committee for the Definition of Cerebral Palsy Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. 2005;47:571–6. - PubMed
    1. Kuban KCK, Leviton A. Cerebral palsy. N Engl J Med. 1994;330:188–95. - PubMed
    1. Cummins SK, Nelson KB, Grether JK, Veile EM. Cerebral palsy in four northern California counties, births 1983 through 1985. J Pediatr. 1993;123:230–7. - PubMed
    1. Robertson CMT, Watt M-J, Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely in a population-based program over 30 years. JAMA. 2007;297:2733–40. - PubMed
    1. Tommiska V, Heinonen K, Lehtonen L, et al. No improvement in outcome of nationwide extremely low birthweight infant populations between 1996-1997 and 1999-2000. Pediatrics. 2007;119:29–36. - PubMed

Publication types

Associated data

Grants and funding